Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

November 15, 2025

Study Completion Date

April 1, 2026

Conditions

Biliary Tract Cancer

Interventions

DRUG

S-1(Intravenous combined with oral)

Oral combined with intravenous S-1 for ctDNA-positive patients (escalating treatment strategy)

Trial Locations (1)

East Hospital, Tongji University School of Medicine, Shanghai

All Listed Sponsors

lead

Shanghai East Hospital

OTHER

NCT06171321 - Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma | Biotech Hunter | Biotech Hunter